Filter
5083
Filtered Results: 5083
Text search:
drug
quality
Featured
Recommendations
460
New Publications
1433
Language
Document type
No document type
3172
Studies & Reports
735
Guidelines
649
Manuals
212
Strategic & Response Plan
146
Fact sheets
66
Training Material
55
Situation Updates
17
Infographics
14
Resource Platforms
9
Brochures
5
Online Courses
2
App
1
Countries / Regions
India
315
Kenya
164
Global
154
South Africa
125
Ethiopia
123
Uganda
120
Western and Central Europe
105
Nigeria
103
Nepal
102
Tanzania
89
Malawi
87
Sierra Leone
85
Liberia
83
Zambia
80
Ghana
73
Africa
69
Bangladesh
69
Myanmar / Burma
68
Latin America and the Carribbean
62
Rwanda
61
Namibia
49
Eastern Europe
47
Ukraine
46
Philippines
41
Cambodia
40
Zimbabwe
39
Lesotho
33
Asia
33
South–East Asia Region
32
Botswana
29
Senegal
27
Congo, Democratic Republic of
27
Russia
25
Indonesia
25
Burkina Faso
21
Syria
20
Mozambique
20
Eswatini/ Swaziland
19
Brazil
18
Haiti
16
East and Southern Africa
15
Cameroon
14
USA
14
West and Central Africa
13
Eastern Europe and Central Asia
13
Tajikistan
11
Germany
11
Middle East and North Africa
11
Georgia
11
South Sudan
11
Colombia
10
Albania
10
Pakistan
10
Thailand
9
Benin
9
Vietnam
9
Afghanistan
8
Venezuela
8
Sudan
8
Laos
7
Guinea
7
North Macedonia
6
Western Pacific Region
6
Moldova
6
China
5
Chile
5
Armenia
5
Paraguay
5
Lebanon
5
Iraq
5
Madagascar
5
Peru
4
Jordan
4
Jamaica
4
United Kingdom
4
Argentina
4
Sri Lanka
4
Mexico
3
El Salvador
3
Turkey
3
Kyrgyzstan
3
Morocco
3
North America
3
Southern Africa
3
Bolivia
3
Bhutan
3
Timor Leste/ East Timor
2
Kazakhstan
2
Iran
2
Fiji
2
Estonia
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Gabon
2
Belgium
2
France
2
Tunisia
2
Portugal
2
Belarus
2
Papua New Guinea
2
Yemen
2
Palestine
2
Central African Republic
2
Poland
2
Mali
2
Libya
2
Somalia
2
Switzerland
1
Serbia
1
Australia
1
Gambia
1
Canada
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Romania
1
Greece
1
Honduras
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
2070
Clinical Guidelines
461
Public Health
258
Women & Child Health
196
Key Resources
101
Pharmacy & Technologies
69
Capacity Building
68
Annual Report MEDBOX
1
Toolboxes
HIV
593
Mental Health
482
TB
468
AMR
275
COVID-19
184
Pharmacy
183
NTDs
136
NCDs
112
Caregiver
106
Rapid Response
75
Planetary Health
66
Refugee
62
Ebola
61
Disability
58
Conflict
53
Global Health Education
51
Health Financing Toolbox
27
Natural Hazards
21
Polio
18
Cholera
14
Social Ethics
14
Zika
11
Specific Hazards
10
Health Financing
1
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
Guidelines for Medicine Donations
recommended
This 3rd edition of Guidelines for medicine donations has been developed by the World Health Organization (WHO) in cooperation with major international agencies active in humanitarian relief and development assistance. The guidelines are intended to improve the quality of medicine donations in inter...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation with patients.
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Expert Consensus Validation 2018.
This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
